Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Mitogen-activated protein kinase (MAPK) >  MEK inhibitor >  U0126-EtOH

U0126-EtOH

Basic information Safety Supplier Related

U0126-EtOH Basic information

Product Name:
U0126-EtOH
Synonyms:
  • CS-2415
  • u 126
  • 2,3-bis(amino(2-aminophenylthio)methylene)succinonitrile,ethanol
  • U0126-ETOH;U 0126;U-0126
  • (2Z,3Z)-2,3-bis[amino-(2-aminophenyl)sulfanylmethylidene]butanedinitrile,ethanol
  • U0126-EtOH
  • 2,3-Bis[amino[(2-aminophenyl)thio]methylene]butanedinitrile ethanol salt
  • (2Z,3Z)-2,3-Bis(amino(2-aminophenylthio)methylene)succinonitrile compound with ethanol (1:1)
CAS:
1173097-76-1
MF:
C20H22N6OS2
MW:
426.56
Product Categories:
  • Inhibitors
  • MAPK
Mol File:
1173097-76-1.mol
More
Less

U0126-EtOH Chemical Properties

storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
solubility 
≥21.33 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
form 
solid
More
Less

Safety Information

HS Code 
29309090
More
Less

U0126-EtOH Usage And Synthesis

Uses

A chemically synthesized and highly selective inhibitor of both MEK1 and MEK2 with IC50s of 70 nM and 60 nM, respectively.

Definition

ChEBI: U0126.EtOH is an addition compound obtained by combining equimolar amounts of (2Z,3Z)-bis{amino[(2-aminophenyl)sulfanyl]methylidene}butanedinitrile (U0126) and ethanol. An inhibitor of mitogen-activated protein kinase that also exhibits anti-cancer properties. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an apoptosis inducer, an antineoplastic agent, an antioxidant, an osteogenesis regulator and a vasoconstrictor agent. It contains an U0126.

Biological Activity

u0126-etoh is a selective inhibitor of mek1 and mek2 with ic50 values of 70 nm and 60 nm, resepctively [1].u0126 was screened out as an anti-inflammatory agent that inhibited ap-1 transcription with ic50 value of 1μm and had no interactions with gres. u0126 binds mek1/2 in a unique site. this inhibition of mek1/2 is noncompetitive with erk and atp. u0126 showed no effects on other mapkks. in ht22 cells, u0126 treatment significantly inhibited the cell injury caused by oxidative glutamate toxicity and remarkably blocked the phosphorylation of erk1/2. besides that, u0126 exerted no neuroprotection against other stimuli such as tnfα and actinomycin d. u0126 treatment also protected the primary cultured cortical neurons from oxidative glutamate toxicity and hypoxia/reoxygenation [1, 2].

target

MEK1

References

[1] duncia j v, santella iii j b, higley c a, et al. mek inhibitors: the chemistry and biological activity of u0126, its analogs, and cyclization products. bioorganic & medicinal chemistry letters, 1998, 8(20): 2839-2844.
[2] satoh t, nakatsuka d, watanabe y, et al. neuroprotection by mapk/erk kinase inhibition with u0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. neuroscience letters, 2000, 288(2): 163-166.

U0126-EtOHSupplier

Nanjing Peiwill Biotechnology Co.,Ltd. Gold
Tel
025-57027729 15850702895
Email
15850702895@163.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Email
sales@trio-pharmatech.com (International market)
More
Less